WHAT IS SEMAGLUTIDE & TIRZEPAPATIDE

Semaglutide is a medication that was originally approved to treat type 2 diabetes. It is a GLP-1 receptor agonist, which means that it mimics the effects of a hormone called glucagon-like peptide-1 (GLP-1) in the body. GLP-1 is produced by the intestines and helps to regulate blood sugar levels by stimulating insulin secretion and reducing the production of glucose in the liver.

Tirzepatide works by interfering with two hormones released after eating. GLP-1 and GIP are the two hormones that imitate how these two hormones act. GLP-1 is an abbreviation for glucagon-like peptide-1, while GIP is an abbreviation for glucose-dependent insulinotropic polypeptide. These hormones play a role in blood sugar regulation. These hormones signal the pancreas to release insulin after eating and the liver to reduce the amount of glucose it produces in healthy people. When these guidelines are followed, people feel full and quit eating, which slows digestion and reduces blood sugar. Tirzepatide helps blood sugar management by mimicking these hormones. So, when blood sugar levels are high, the medicine helps the body release insulin and eliminate excess sugar from the body.

These medications both promote weight loss by reducing appetite and increasing feelings of fullness. It works by activating receptors in the brain, which control hunger and satiety. When these meds are taken, it binds to these receptors and sends a signal to the brain that the stomach is full. This reduces feelings of hunger and promotes a sense of fullness, leading to a decrease in food intake. In addition to reducing appetite, these medications also slow down the rate at which food leaves the stomach. This leads to a longer feeling of fullness, which can help to reduce snacking and overeating.

Clinical studies have shown that Semaglutide is effective in promoting weight loss. In a recent study, researchers found that people who took Semaglutide lost an average of 15% of their body weight over the course of 68 weeks. Studies on Tirzepatide for weight loss have shown that nearly 75% of clinical trial participants lost at least 20% of their body weight. This is a significant amount of weight loss and can lead to improvements in overall health and a reduction in the risk of obesity-related health problems. In addition to weight loss, both have been shown to have other health benefits. It can improve blood sugar control in people with diabetes, reduce the risk of heart disease, and improve cholesterol levels.

These medications are generally considered safe when used as directed. However, like all medications, it can cause side effects. Common side effects include nausea, vomiting, diarrhea, and constipation. These side effects are usually mild and go away on their own. In rare cases, these medications can cause more serious side effects, such as pancreatitis, gallbladder issues or kidney problems. It is important to talk to a healthcare professional before starting these medications to discuss the potential risks and benefits.

Semaglutide and Tirzepatide may be suitable for use in adults with a body mass index (BMI) of 30 or higher, or adults with a BMI of 27 or higher who also have at least one weight-related health problem, such as type 2 diabetes, high blood pressure, or high cholesterol. It is not recommended for use in children or adolescents at the moment.

The doctor will review your medical history prior to your initial appointment based on your Medical Intake form. These medications may not be advised for use in some situations. For instance, you cannot take any GLP-1s with another GLP-1 drug if you are already on one. Patients who also have the following are not good candidates for this medication: History or family history of Medullary Thyroid Carcinoma (MTC) Have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) Type 1 Diabetes or Type 2 Diabetics already on GLP-1 medication Past History of Pancreatitis or Chronic Kidney Disease (unless medically cleared) Have had a serious allergic reaction to Semaglutide or Tirzepatide If you are trying to conceive, nursing, or already pregnant

These medications are taken as a once-weekly injection. It is available in a vial that can be drawn up with a tiny syringe that can be self-administered. A licensed healthcare professional may also assist the customer with weekly injections. The injection is given subcutaneously (fatty tissue under the skin) typically in the abdomen, thigh, or upper arm. In addition to taking these medications, it is important to make lifestyle changes to support weight loss. This may include eating a healthy diet, exercising regularly, getting enough sleep, and managing stress.